Black Walnut | Juglans Nigra | Foraging for Wild Edible Plants and Medicine
This is a species of walnut (Genus Juglans). The black walnut (Juglans nigra) based on the shape of the fruit. There is a wonderful medicine to be derived fr...
By: Mariana Roberts
Originally posted here:
Black Walnut | Juglans Nigra | Foraging for Wild Edible Plants and Medicine - Video
Thousands of American soldiers and millions of civilians could avoid noise-related hearing loss if the final stage of research, scheduled to begin next month at a U.S. Army base, continues to prove the benefit of a protective medicine invented by a scientist at Springfields Southern Illinois University School of Medicine.
I want to see this over the finish line, said Kathleen Campbell, an SIU faculty member for almost 25 years and the medical schools first researcher to bring an invention to the highest level of testing a Phase 3 clinical trial on the path to Food and Drug Administration approval.
Campbell has developed an orange-flavored liquid containing a concentrated form of a substance called D-methionine, or D-met. A component of protein commonly found in cheese and yogurt, D-met has been shown in several studies by Campbell and other scientists in the United States and abroad to slow the development of the free radicals that can lead to long-term hearing loss after exposure to loud noise.
Five years away? The Phase 3 trial, lasting for two years, will test the effectiveness of up to four daily tablespoons of D-met syrup taken by drill-sergeant instructor candidates during two weeks of training at Fort Jackson in South Carolina.
They fire exactly 500 rounds of M16 weapon fire in 11 days, Campbell said. Its a double-blind, placebo-controlled clinical trial. At the end of the trial, we should have less permanent hearing loss in those that are on D-met rather than the placebo.
A total of 600 soldiers will take part in the study as part of a $2.5 million grant Campbell received from the U.S. Department of Defense.
If Campbell can secure financial support from a private company willing to license her patents for D-met and fund a second required Phase 3 trial, the medicine could receive FDA approval and be on the market in as soon as five years, she said.
Studies so far indicate the medicine could be taken before, during and up to three days after the noise exposure and still help cells in the inner ear recover. Body type J: Theyre damaged, theyre floating in all of these toxins, but theyre still alive, Campbell said.
Medicinal first f brought to market, her invention would be the first medicine proven to prevent noise-induced hearing loss, the most-common cause of hearing loss worldwide.
This problem costs the federal government at least $2 billion a year in medical costs and disability payments for active and retired military personnel, Campbell said.
The rest is here:
SIU inventor's medicine to protect hearing nears final research phase
HOUSTON, TX--(Marketwired - September 20, 2013) - The Primary Care Sports Medicine (PCSM) Fellowship program at Houston Methodist Orthopedics & Sports Medicine strengthens its footing within Houston and advances the scope of sports medicine, as its first fellows graduate and two more begin.
The Houston Methodist Willowbrook Hospital PCSM program along with its sister program at Houston Methodist Sugar Land Hospital are unique in that they are both attached academically to the same family medicine residency program, which is also run by Houston Methodist Hospital.Together, they represent the largest Primary Care Sports Medicine training program in Texas. The program provides fellows with a broader understanding of the unique needs of the athletic population -- setting a unique precedence in sports medicine training.
According to PCSM Fellowship Director Scott Rand, M.D., FAAFP CAQSM, the fellows receive multidisciplinary training on advanced diagnosis and treatment of musculoskeletal injuries and concussions.They also gain a detailed understanding of the relationship between exercise and certain medical conditions.
In addition to injuries typically associated with sports medicine, such as sprains, ligament and tendon injuries and fractures and dislocations, PCSM also involves the overall medical care of athletes and active patients of all ages.Concussions, asthma, heart problems, diabetes and nutrition and exercise are also among the issues on which PCSM doctors focus and fellows are specifically trained.
In 2011 the program received accreditation by the Accreditation Council for Graduate Medical Education (ACGME) through a peer review process and thorough evaluation of established standards and guidelines.There are just 120 accredited programs around the country.
"We are training a new type of specialist, who has the training and experience to care for athletes. In an era of concussion management and the renewed focus on fitness and exercise in medicine, primary care sports medicine doctors specialize in the overall needs of the athlete," said Rand, who is also the director of the first Houston Methodist Human Performance Lab.
"The primary care sports medicine fellowship program is unlike any other that currently exists in the United States -- supported entirely by the hospital with no government funding. We are fortunate that Houston Methodist Hospital sees the value that this specialty has and the need the community has for it -- choosing to fund these programs internally," added Rand.
Rand, who is board certified in family medicine with certificate of added qualifications (CAQ) in sports medicine, oversees all aspects of training and education that the fellows receive -- including experience treating a broad range of injuries and conditions, computerized neuropsychological testing in concussion management, electrophysiology, and other elective rotations in Orthopedic subspecialties, cardiology, and neuropsychology.
According to Beryl Ramsey, chief executive officer, Houston Methodist Willowbrook Hospital and senior vice president of Houston Methodist Hospital the PCSM Fellowship is a significant accomplishment and part of an ongoing commitment to both anticipate and meet the community's needs.
"We recognize the value of such a program -- providing physicians with the skills necessary to care for all of the needs of an active population. This is particularly important today as we stay active longer," added Ramsey.
Here is the original post:
Bad Medicine Bubbas Mud Ranch Run 2 9/14/2013
Subscribe at: http://youtube.com/subscription_center?add_user=senseimudtruck Like us on Facebook!: http://www.facebook.com/senseimudracing All video owned by...
By: Sensei Productions
Continued here:
Medicine Ball Hopping Slam
Check out more videos like this, please visit http://www.MovementTheory.com Personal Trainer, Theo Simon from San Diego, demonstrates a Medicine Ball Hopping...
By: Movement Theory
The rest is here:
"Dixieland Delight" - Old Crow Medicine Show (from High Cotton : A Tribute to Alabama)
"Dixieland Delight" performed by Old Crow Medicine Show (from High Cotton: A Tribute to Alabama). The album is in stores 9/21. http://www.lightningrodrecords.com.
By: lightningrodrecords
More here:
"Dixieland Delight" - Old Crow Medicine Show (from High Cotton : A Tribute to Alabama) - Video
Can Foods Make Us Sick? Nutrition, Chronic Disease, Healthy Diet, Medicine, Natural Food Info
Friend us!! http://www.Facebook.com/psychetruth Can Foods Make Us Sick? Nutrition, Chronic Disease, Healthy Diet, Medicine, Natural Food Info Holistic Health...
By: psychetruth
Read more:
Survival Medicine Handbook 2nd Edition Review by Equip 2 Endure
Like this video and the information E2E has to offer? Donate here: https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick hosted_button_id=KW369X2EE9C8N -------...
By: Equip 2 Endure LLC
Read more here:
Survival Medicine Handbook 2nd Edition Review by Equip 2 Endure - Video
ATLANTA, Sept. 19, 2013 (GLOBE NEWSWIRE) -- The Morehouse School of Medicine (MSM) will induct 70 new MD students, 83% from Georgia, on Friday, September 20. MSM's Annual Convocation and White Coat Ceremony formally mark the start of medical education for a total of 129 students, including 59 in other advanced medical degree programs. The ceremony will begin at 10 a.m. in the auditorium of the National Center for Primary Care on the school's campus.
As MSM's largest MD class, students were carefully selected from a group of 4,767 applications - a record number for the medical school. They began orientation on Monday, July 1 and started classes Wednesday, July 3; 61 percent are women, while 39 percent are men.
Other programs began through out the fall with the following number of participants:
.
19 in Masters of Public Health .
6 Masters in Science in Clinical Research .
6 Ph.D. in Biomedical Sciences .
12 Masters of Science in Biomedical Research .
16 Masters of Science in Medical Sciences
MSM President John E. Maupin Jr., DDS, will address the students, their friends and family members about the importance of this day and the days ahead. During the ceremony, students will take their first oath of professional medical ethics, concluding with the words, "I commit myself to a lifelong journey of learning how to cure, relieve and comfort with humility and compassion."
See the original post:
Morehouse School of Medicine Officially welcomes the class of 2017
Public release date: 19-Sep-2013 [ | E-mail | Share ]
Contact: Kathy Ridgely Beal kbeal@acmg.net 301-238-4582 American College of Medical Genetics
September 19, 2013 Bethesda, MD Genetic tests can now tell us whether we are at increased risk of various cancers, heart or kidney disease, asthma and a number of other conditions.
Other genetic tests can tell whether you will respond to certain medicines or be harmed by side effects linked to your genetic code. But harnessing that information to benefit individual patients and prevent illnesses in others will require that doctors have access to genomic information for each patient. As health records are converted to digital form, the most likely place to store and retrieve genomic information will be Electronic Health Records (EHR). But when and how that happens will depend on having good models to build upon.
Now, in the first collection of its kind, the October 2013 issue of Genetics in Medicine, the official peer-reviewed journal of the American College of Medical Genetics and Genomics, provides a series of research articles detailing challenges and solutions for integrating genomic data into EHR. The issue features the insights of research teams actively engaged in integrating genomic medicine into clinical care. Most of the contributions derive from the experiences of individual sites that comprise the Electronic Medical Records and Genomics (eMERGE) Network, a national consortium funded by the National Institutes of Health, but additional perspective is provided by a commercial EHR vendor and by the Clinical Sequencing Exploratory Research (CSER) consortium, a cooperative group exploring applications of genomic sequencing.
"Our hope is that this issue of Genetics in Medicine will serve as a 'how to' and 'what to think about' for any group tasked with launching a genomics program and integrating this data into the EHR at the point of care," said Joseph Kannry, MD, a board-certified internist and Lead Technical Informaticist of the Epic Clinical Transformation Group, Mount Sinai Medical Center, New York, NY. "This issue should serve as a reference point for many years to come."
Dr. Kannry and co-editor Marc Williams, MD FACMG, director of the Genomic Medicine Institute, Geisinger Health System, Danville, Pa., steered the effort to organize contributions and together wrote the lead editorial. In it they state that, "Successfully integrating genomics into clinical care requires a vision, a strategy that will achieve the vision, and an actionable implementation plan." The case studies provided in this special issue outline the following challenges and potential solutions:
How can genomics be meaningfully incorporated into routine healthcare? [Hartzler et al. doi: GIM.2013.127] describe how a broad range of parties, including institutional leadership, physicians, information technology staff, and patients must be included in the conversation if genomic medicine is to be successful. The article describes different ways to ensure support systems are in place when launching a genomic medicine project.
How will genomic data be stored, processed, updated and retrieved? [citation: Kho et al. doi: GIM.2013.131] examine data currently captured in EHR systems and compare that to genomic data. They look forward to the need for long-term storage and retrieval and how data can be accessed and compared across time and in changing clinical circumstances.
Likewise, [Chute et al. doi: gim.2013.121] discuss the opportunities for large data sets of genomic information to help detect new genomic risk factors and clinically important information not possible until recently. They identify gaps in standards for coding and transmission of data and propose solutions.
See original here:
Genetics in Medicine publishes special issue dedicated to genomics in electronic health records
WALTHAM, Mass., Sept. 19, 2013 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders announced today a series of events related to galectin-3 and heart failure during the 17th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) taking place on September 22nd-25th, 2013 in Orlando, Florida.
On Sunday, September 22nd, immediately following the opening session, BG Medicine will co-sponsor an Early Career Professionals Reception with Boston Scientific Corporation. This event provides a rare opportunity for early career professionals to meet mentors and talk with some of the most respected heart failure specialists in America.
Galectin-3 will be featured in several oral presentations at the meeting including one entitled, "Novel Biomarkers for Heart Failure -- Eventual Targets for Therapy" on Monday, September 23rd at 4:00pm Eastern Time. Christopher deFilippi, MD, Associate Professor of Medicine at the University of Maryland will discuss Galectin-3 and the prognosis in heart failure during this presentation.
On Tuesday, September 24th, there will be a Galectin-3 presentation by Alan Maisel, MD, Professor of Medicine and Director of the Coronary Care Unit at the University of California San Diego and Michael Zile, MD, Principal Investigator at the Gazes Cardiac Research Institute and Professor of Medicine at Medical University in Charleston, South Carolina. The title of the program is "Development, progression and hospitalization for heart failure: targeting fibrosis" and will take place at 12:45pm Eastern Time in The Peabody Hotel Exhibit Hall. This program will address the role of Galectin-3, a marker implicated in cardiac fibrosis, in the development of heart failure (HF) and how to use a biomarker guided approach to identify patients at high risk for near term hospitalization and mortality.
About Galectin-3 Testing and Heart Failure
Galectin-3 has been implicated in a variety of biological processes important in the development and progression of heart failure. Higher levels of galectin-3 are associated with a more aggressive form of heart failure, which may make identification of high-risk patients using galectin-3 testing an important part of patient care. Galectin-3 testing may be useful in helping physicians determine which patients are at higher risk of death or hospitalization, including 30-day readmission. The BGM Galectin-3(R) blood test is to be used as an aid in assessing the prognosis of patients with chronic heart failure, in conjunction with clinical evaluation. For more information visit http://www.galectin-3.com
About BG Medicine, Inc.
BG Medicine, Inc. (BGMD) is a commercial stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.BG-medicine.com. The BG Medicine Inc. logo is available for download here
Read more here:
Dr. Robert Gleeson, Executive Health Program Director, internal medicine physician
David Goldberg, MD, is an internal medicine physician with Froedtert The Medical College of Wisconsin. http://doctors.froedtert.com/PhysicianDirectory/Glee...
By: Froedtert
Link:
Dr. Robert Gleeson, Executive Health Program Director, internal medicine physician - Video
(l-r): Pete Fisher, Opry Vice President and General Manager; Dierks Bentley; Marty Stuart; Old Crow Medicine Show. Photo by Chris Hollo, courtesy of Schmidt Relations.
Modern-day string band Old Crow Medicine Show was formally inducted into the Grand Ole Opry last night by Opry members Dierks Bentley and Marty Stuart. Among the award-winning groups first performances in Nashville were on the sidewalks outside the Opry House in Summer 2000, playing for fans entering and exiting Opry performances. The band graduated to the Opry stage for its official Opry debut on Jan. 13, 2001, quickly became a fan favorite during dozens of Opry performances since, and was invited by Stuart to join the Opry on Aug. 16 in Cleveland, Ohio.
Just before show time, the band reprised its Opry Plaza performances from more than a dozen years ago, walking outside the Opry House and playing tunes including Brave Boys and Hesitation Blues for surprised fans waiting outside for the evenings Opry show.
Onstage later in the night, Opry Vice President and General Manager Pete Fisher and Opry members Dierks Bentley and Stuart took the stage alongside Old Crow Medicine Show, presenting the group with its Opry member award. Congratulations, Old Crow, on being a part of the coolest club there is, Bentley said.
Addressing the band, Marty added, You offer a whole new energy and love for country music in the 21st century.
Speaking on behalf of the group, Ketch Secor related that years ago members of the band asked themselves if theyd ever make it big in TV. Secor recalled having said, I dont know about TV, but we might make something of ourselves on radio. Fast forwarding to tonights show, Secor concluded, Were standing out here on the most beloved broadcast anywhere on earth. I think we made it big on radio! We, the Old Crows, are just so proud to be entrusted to carry on the traditions of the Grand Ole Oprys good-natured riot.
After tearing into the bands signature song, Wagon Wheel, (currently covered by fellow Opry member Darius Rucker) the group invited fellow Opry members Bentley, Stuart, Connie Smith, and the Del McCoury Band to join them on the standards Will The Circle Be Unbroken and I Saw The Light.
Old Crow has over the years become a favorite of Opry audiences and everyone backstage, as well, said Fisher. Its fun for so many of us that in many ways Old Crow looks and sounds a lot like some of the great early Opry bands like Roy Acuff and his Smoky Mountain Boysbands which helped propel the Opry to national prominence. Tonight represents a great full circle, and as the great Jimmy Dickens says, The circle cant be broken.
After the induction, the group added a plaque bearing its name to the Opry Member Gallery backstage at the Opry House.
Old Crow Medicine Show is scheduled to perform concerts on Dec. 30 and Dec. 31 at the Ryman Auditorium. Tickets will go on sale Sept. 27 at 10 a.m.
See original here:
WHAT: Penn Medicine will celebrate one of the largest capital projects in the history of Pennsylvania Hospital, the official opening of Penn Medicine Washington Square a new 153,000 square foot, green building in center city Philadelphia that serves as the major hub of outpatient care for Pennsylvania Hospital. This modern facility features leading-edge telecommunication and clinical information systems, providing patients with the most advanced level of collaborative and interdisciplinary care.
More than 100 providers from across a wide range of services including cardiology, concierge medicine, otorhinolaryngology, primary care, surgery and womens health are now available in one location along with patient pre-admission testing and phlebotomy services. The facility is also built atop an existing parking garage, offering added convenience for patients.
Penn Medicine Washington Square is an integral part of Pennsylvania Hospitals master plan which includes the expansion of private rooms for our patients. It represents great strides in both meeting the growing need for outpatient care and Penn Medicines overall commitment to its patients in Center City and beyond.
Tours of Penn Medicine Washington Square will be available and will include: a patient exam room, diagnostic space; patient waiting areas and lobbies; and the new Avenue C self-checkout vending market for employees.
**More information below
WHEN: Thursday, September 19, 2013 5:30 PM 7:00 PM Remarks to begin at 6:15 PM
WHERE: Penn Medicine Washington Square 800 Walnut Street Philadelphia, PA
WHO: Speakers & Special Guests
J. Larry Jameson, MD, PhD Executive Vice President, University of Pennsylvania for the Health System Dean, Perelman School of Medicine at the University of Pennsylvania
Amy Gutmann, PhD President, University of Pennsylvania
More:
Grand Opening of New Philadelphia Outpatient Medical Facility: Penn Medicine Washington Square
The growth of personalised medicine threatens the communal approach that has brought our biggest health gains
ADVOCATES of personalised medicine claim that healthcare isn't individualised enough.
Backed up by the glamour of new biotechnologies such as direct-to-consumer genetic testing, personalised medicine what I call "Me Medicine" appears to its advocates as the inevitable and desirable way to go. Barack Obama, when still a US senator, declared that "in no area of research is the promise greater than in personalised medicine".
This trend towards Me Medicine is led by the US, but it is growing across the developed world.
In contrast, "We Medicine" public-health programmes such as flu shots or childhood vaccination is increasingly distrusted and vulnerable to austerity cuts. Yet historically this approach has produced the biggest increase in lifespan. Even today, countries with more social provision of healthcare and less individualistic attitudes have better health outcomes across all social classes.
Contrary to the claims of its proponents, the personalised approach hasn't yet delivered a paradigm shift in medicine. A 2012 Harris poll of 2760 US patients and physicians found that doctors had recommended personal genetic tests for only 4 per cent of patients. The Center for Health Reform & Modernization, run by US healthcare company UnitedHealth, put the figure at just 2 per cent.
But money is still pouring into Me Medicine. In July, the UK government announced that it would offer private companies a subsidy from a 300 million fund to encourage investment in its personalised medicine initiative, Genomics England. Last year the US administration increased the National Institutes of Health budget for personalised medicine, while cutting the budget for the Centers for Disease Control and Prevention's Office of Public Health Genomics by 90 per cent.
Of course it would be nice if we could afford both, but in reality there's a growing risk that "me" will edge out "we". If it does, it won't be because the science is better or the outcomes more beneficial. In some instances of Me Medicine, clinical outcomes are worse than the We equivalent. For example, according to the UK's Royal College of Obstetricians and Gynaecologists, private umbilical cord blood banks, which ostensibly provide a personal "spare parts kit" for the baby, produce poorer outcomes than public cord blood banking.
It is true that in some areas of Me Medicine, such as genetically individualised drug regimes for cancer care (technically known as pharmacogenetics), there has been genuine progress. For example, vemurafenib, a drug for aggressive melanoma, was reported in a 2012 New England Journal of Medicine article to extend the lifespan of 1 in 4 patients by seven months if they carry a specific genetic mutation in their cancer.
But only about half of those with the "right" type of tumour responded, and the mutation in question only occurs in about half of such melanomas. What is more, pharmaceutical firms will probably charge more for such drugs than for mass-market ones. They will be expensive, may benefit only a subset of the population and could leave cash-strapped state healthcare systems facing difficult decisions about where to allocate resources.
Follow this link:
Public release date: 17-Sep-2013 [ | E-mail | Share ]
Contact: Bob Nellis newsbureau@mayo.edu 507-284-5005 Mayo Clinic
ROCHESTER, Minn.-- From Promise to Practice is the title and the main message of the second annual Individualizing Medicine Conference at Mayo Clinic, Sept. 30-Oct. 2. Physicians from more than 40 states and several countries will be arriving in Minnesota to hear and learn about the latest developments and research in genomic research and how to move these discoveries into the medical practice.
"Our goal is to inform practicing physicians, but other care providers, students, media and the public as well," says Richard Weinshilboum, M.D., chair of this year's conference held by Mayo Clinic's Center for Individualized Medicine. "Individualizing prevention, diagnosis and treatment is the core of medical genomics and the future of medicine. Even if you missed the last 13 years since the mapping of the human genome, we'll help you catch up in three days."
Opening keynote speaker on Monday, September 30, will be Eric Green, M.D., Ph.D., director of the National Institute of Genomic Health Research, Bethesda, M.D. Co-hosts for the conference will be Richard Besser, M.D., chief health and medical editor for ABC News and former acting director of the Centers for Disease Control, and Ceci Connolly, managing director of the Health Research Institute, PwC.
The conference offers expert speakers, focused breakout sessions, and real-life case studies so participants can discover and discuss emerging topics in medical genomics. Topics range from translating genomic findings into clinical care to communicating accurately and ethically with patients. Also this year, on Sunday Sept. 29, an "Omics 101" seminar will be offered at a lay level for those new to individualized medicine. This course is being offered separately and is ideal for students and media who will be working in or reporting on the genomics field.
Individualized medicine is a growing field of patient care based on the increasing knowledge of the human genome, mapped just a decade ago. Mayo Clinic is a leader in transferring medical genomics to medical practice clinomics as evidenced by its Individualized Medicine Clinic, launched a year ago. Mayo's Center for Individualized Medicine also includes programs in biomarker discovery, pharmacogenomics, epigenomics and the human microbiome.
Individualizing Medicine 2013 is supported by the Satter Foundation.
###
About Mayo Clinic
View post:
Mayo Clinic hosts NIH genomics director at Individualizing Medicine Conference
BOSTON--(BUSINESS WIRE)--
Harvard Business Review (HBR) and the New England Journal of Medicine (NEJM) today launched the Leading Health Care Innovation Insight Center, an eight-week online forum dedicated to helping leaders, managers, and other decision makers in health care improve patient outcomes and lower the cost of care.
The Insight Center runs from September 17 through November 15 and offers daily posts, peer-reviewed reports, and interactive content on topics such as leadership, strategy, organizational design, and talent management. Articles will examine specific tactics being applied in health care systems today to reduce costs and improve quality.
As part of the forum, Michael E. Porter, Harvard Business School professor and one of the worlds most respected thinkers on competitive strategy, and Thomas H. Lee, Chief Medical Officer of Press Ganey and former Network President and CEO for Partners Community HealthCare, Inc., will host a webinar on Sept. 24 at 12 p.m. ET to discuss their article from HBRs October issue, The Strategy That Will Fix Health Care.
Were excited to partner with the New England Journal of Medicine to explore how managers and decision makers can transform health care around the world, said Adi Ignatius, HBR Editor in Chief. Our goal is to promote discussion among physicians, health care leaders, clinicians, and policymakers about value and innovation in health care.
The collaborative publishing project between the Journal and the Harvard Business Review comes at a turning point in American health care, said Gregory D. Curfman, M.D., NEJM Executive Editor. Never before have the interests of the health care community and the business community been better aligned.
The Insight Centers advisory board includes distinguished leaders from medicine, business, and academia, among them the CEOs of Cleveland Clinic, Mayo Clinic, and Emory Healthcare.
Visit the Leading Health Care Innovation Insight Center at hbr.org/insights/healthcare or follow it on Twitter at @HBRhealth.
About Harvard Business Review
Harvard Business Reviewis the leading destination for smart management thinking. Through its flagship magazine, 12 international licensed editions, books from Harvard Business Review Press, and digital content and tools published onHBR.org,Harvard Business Reviewprovides professionals around the world with rigorous insights and best practices to lead themselves and their organizations more effectively and to make a positive impact.
More:
HARTFORD, Conn.--(BUSINESS WIRE)--
The Tour for Diversity in Medicine will travel the Northeast corridor to introduce medicine and dentistry as a field of advanced study and career path to minority students from September 23-28, 2013. Along with Tour partner the Aetna Foundation, more than 15 doctors, dentists and medical school students from across the country will participate in the program, which will provide full-day, hands-on workshops to undergrad students in six states. For the first time, the Tour will also engage with high school students, in addition to college undergraduates, during the Tours final stop in Washington, D.C.
The Tour will travel 400 miles over six days making six different stops at locations including two historically black colleges and universities. The participating medical professionals will hold conversations with hundreds of potential medical and dental professionals over the course of the week. The Tour for Diversity in Medicines mission is to help diversify the health care profession by giving minority students the advice and tools they will need to pursue medical careers.
Although African Americans, Hispanics and Native Americans compose more than 26 percent of the U.S. population, they represent only six percent of practicing physicians and five percent of dentists, according to the Association of American Medical Colleges (AAMC). In 2011, African-American and Hispanic students made up only 15 percent of all U.S. medical school applicants.1 Yet research shows that patients who receive care from doctors of the same background are more satisfied with their care and more engaged in their treatment.
Our mission is to make a tangible difference in the lives of students and the broader community by offering the vision and real-world strategies to overcome barriers to address the need for greater diversity in the medical profession. Bridging the health-equity gap for under-represented minorities will only happen if our next generation is ready to meet the challenge, said Alden Landry, M.D., co-founder of the Tour for Diversity in Medicine and an emergency department physician at Beth Israel Deaconess Medical Center in Boston. By reaching students early, even at the high school level, and engaging in face-to-face sessions with professionals who come from similar backgrounds, we hope to empower students to consider a career in medicine early on and to imagine whats possible for patients and their communities with a more diverse physician population.
The week of September 23, the Tour for Diversity in Medicine will travel to:
Garth Graham, M.D., M.P.H., president of the Aetna Foundation, said, As our nations population becomes increasingly diverse, we need to ensure that future health care providers reflect the racial and ethnic diversity that will help further positive health outcomes today and for future generations.As the Tours founding sponsor, we are pleased to offer our support to this innovative initiative that takes concrete steps to help under-represented minorities see a path forward to a career in medicine.
Aetna is offering further support to the Tour by hosting a workshop on Monday, September 23 at its Hartford headquarters for more than 100 college students from the University of Connecticut, St. Josephs University, Quinnipiac University and other area educational institutions.
Each university campus tour stop involves a full-day session about the medical school application process, admissions tests, financial aid, interviewing skills and an overview of health disparities. Students interact one-on-one with mentors who will offer personal insights and share their experiences about how to build a successful career in medicine or dentistry. Unique this year, high school students will participate in sessions at Georgetown University School of Medicine to help set them up for college academic success and expose them to courses on topics including, Building Academic Habits, College Readiness 101 and Interactive Healthcare Skills.
Along the way, the enthusiasm weve received from students has propelled us to reach more than 1,400 students in the dozen states weve visited on past Tours. We look forward to tracking these students as they begin their journeys toward a career in medicine, said Kameron Matthews, M.D., J.D., co-founder of the Tour for Diversity in Medicine and medical director of the Division Street site of Erie Family Health Center in Chicago. We volunteer our time and log the miles because we are committed to giving back on behalf of the mentoring we received in our careers. If we are able to spark interest in a career in medicine, this cycle of mentorship has been paid forward again.
See the original post:
BOCA RATON, FL--(Marketwired - Sep 17, 2013) - Modernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based specialty-specific electronic medical record (EMR) system, is marking the important role health information technology plays in improving healthcare delivery in America by celebrating National Health Information Technology (NHIT) Week, September 16-20, 2013.
Health information technology improves the quality of healthcare delivery, increases patient safety, decreases medical errors and strengthens the interaction between patients and healthcare providers.
"We have seen our EMA technology help physicians practice medicine more effectively," said Daniel Cane, President and CEO of Modernizing Medicine. "We're harnessing the benefits of medical data to improve clinical outcomes and make medicine more evidence-based in the specialty and sub-specialty markets. Our participation in NHIT Week highlights our commitment to work with our partners and colleagues to better our healthcare system. In addition, we are thrilled that EMA Plastic Surgery and EMA Cosmetic Medical Director Dr. Tim Sayed represents Modernizing Medicine year-round on the HIMSS Electronic Health Record Association Executive Committee."
For additional information about National Health IT Week, visit http://www.healthitweek.org/.
About Modernizing Medicine
Modernizing Medicine is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Its product, Electronic Medical Assistant (EMA), is a cloud-based, specialty-specific electronic medical record (EMR) system with a massive library of built-in medical content, designed to save physicians time. Available as a native iPad application or from any web-enabled Mac or PC, EMA adapts to each provider's unique style of practice and is designed to interface with hundreds of different practice management systems. Today, Modernizing Medicine provides specialty-specific offerings for the dermatology, ophthalmology, optometry, orthopedics and plastic and cosmetic surgery markets, and to more than 1,100 physician practices across the country. In 2013 Modernizing Medicine was listed on Forbes' annual ranking of America's Most Promising Companies.
About National Health Information Technology Week
Now in its eighth year, National Health IT Week is a collaborative forum assembling key healthcare constituents -- vendors, provider organizations, payers, pharmaceutical/biotech companies, government agencies, industry/professional associations, research foundations, and consumer protection groups -- working together to elevate national attention to the necessity of advancing health IT. Log onto http://www.healthitweek.org for more information.
Read more from the original source:
Modernizing Medicine Celebrates National Health IT Week September 16-20, 2013
Dr. Stephen Malcom, internal medicine physician and pediatrician
Stephen Malcom, MD, is an internal medicine physician and pediatrician with Froedtert The Medical College of Wisconsin. Dr. Malcom sees patients at Plank R...
By: Froedtert
Read more:
Dr. Stephen Malcom, internal medicine physician and pediatrician - Video